This article is more than 5 years old. Information may no longer be current.

Merck reports $5.8 billion in global sales in first quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WHITEHOUSE STATION, N.J — Merck & Co. Inc. reported $5.8 billion in worldwide sales for the first quarter of 2008, up 1% from sales in the first quarter of 2007, the company announced in a press release. Specifically, foreign exchange favorably affected global sales by 4% for the quarter, the release said.

Merck's net income totaled $3.3 billion for the first quarter, or $1.52 per diluted share, up 94% from $1.7 billion, or $0.78 per diluted share, in last year's first quarter.

Non-GAAP earnings per share totaled $0.89, excluding a $1.4 billion net after-tax gain from a distribution received through a limited partnership with AstraZeneca, as well as restructuring charges.